Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LPL | P06858 | 2/20 | 0.50 |
| ▸ | LIPG | Q9Y5X9 | 2/20 | 0.50 |
| ▸ | SPHK2 | Q9NRA0 | 4/20 | 0.44 |
| ▸ | SPHK1 | Q9NYA1 | 3/20 | 0.44 |
| ▸ | PPARG | P37231 | 3/20 | 0.44 |
| ▸ | PPARA | Q07869 | 3/20 | 0.44 |
| ▸ | CYP4F2 | P78329 | 2/20 | 0.43 |
| ▸ | CYP4A11 | Q02928 | 2/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2279353 | 1.00 | LPL (0.50) | LPLLIPGSPHK2SPHK1PPARG | |
| SCHEMBL6689640 | 1.00 | LPL (0.50) | LPLLIPGSPHK2SPHK1PPARG | |
| SCHEMBL9542825 | 1.00 | LPL (0.50) | LPLLIPGSPHK2SPHK1PPARG | |
| SCHEMBL207034 | 1.00 | LPL (0.50) | LPLLIPGSPHK2SPHK1PPARG | |
| SCHEMBL27788514 | 1.00 | LPL (0.50) | LPLLIPGSPHK2SPHK1PPARG | |
| SCHEMBL6687168 | 1.00 | LPL (0.50) | LPLLIPGSPHK2SPHK1PPARG | |
| SCHEMBL28158238 | 0.99 | LPL (0.49) | LPLLIPGSPHK2SPHK1PPARG | |
| SCHEMBL28741413 | 0.88 | KAT6A (0.41) | LPLLIPGPPARGPPARACYP4F2 | |
| SCHEMBL10598225 | 0.85 | PPARA (0.47) | LPLLIPGSPHK2SPHK1PPARG | |
| SCHEMBL7910552 | 0.82 | LPL (0.53) | LPLLIPGSPHK2SPHK1PPARG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-101736158-B | Copper extracting agent | ZHENGZHOU DEZHONG CHEMICAL REAGENT FACTORY | 2012-12-19 | — | — | CN | claimed |
| WO-1993016204-A2 | PROCESS AND APPARATUS FOR EXTRACTING SOLUTES FROM THEIR AQUEOUS SOLUTIONS | COGNIS, INC. (US) | 1993-08-19 | — | — | WO | claimed |
| CN-101736158-B | Copper extracting agent | ZHENGZHOU DEZHONG CHEMICAL REAGENT FACTORY | 2012-12-19 | — | — | CN | disclosed |
| CN-101736158-A | Copper extracting agent | ZHENGZHOU DEZHONG CHEMICAL REA | 2010-06-16 | — | — | CN | disclosed |
| US-7585475-B2 | Highly-conductive copper extractant formulations | COGNIS IP MANAGEMENT GMBH (DE) | 2009-09-08 | — | — | US | disclosed |
| EP-2049468-A2 | HIGHLY-CONDUCTIVE COPPER EXTRACTANT FORMULATIONS | Cognis IP Management GmbH (DE) | 2009-04-22 | — | — | EP | disclosed |
| WO-2008021129-A2 | HIGHLY-CONDUCTIVE COPPER EXTRACTANT FORMULATIONS | COGNIS IP MANAGEMENT GMBH (DE) | 2008-02-21 | — | — | WO | disclosed |
| US-20080035893-A1 | Highly-conductive copper extractant formulations | COGNIS IP MANAGEMENT GMBH (DE) | 2008-02-14 | — | — | US | disclosed |
| EP-0706510-B1 | OXIMATION PROCESS | HENKEL CORP (US) | 1998-10-28 | — | — | EP | disclosed |
| EP-0706510-A1 | OXIMATION PROCESS | HENKEL CORPORATION (US) | 1996-04-17 | — | — | EP | disclosed |
| EP-0706510-A4 | OXIMATION PROCESS | HENKEL CORP (US) | 1996-02-19 | — | — | EP | disclosed |
| US-5488161-A | REACTION OF KETONE OR ALDEHYDE WITH HYDROXYLAMINE IN THE PRESENCE OF PHASE TRANSFER CATALYST, ALKYLPHENOL AND CARBOXY ACID OR BASE | HENKEL CORPORATION (US) | 1996-01-30 | — | — | US | disclosed |
| WO-1995001957-A1 | OXIMATION PROCESS | HENKEL CORPORATION (US) | 1995-01-19 | — | — | WO | disclosed |
| US-5349088-A | Reaction of ketone or aldehyde with hydroxylamine in presence of alkylphenol phase transfer catalyst | HENKEL CORPORATION (US) | 1994-09-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080035893-A1 | Highly-conductive copper extractant formulations | KMO, PNPO, SOD1 | LPL 3506/4885LIPG 3088/4885SPHK2 1901/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.